Crossmark Global Holdings’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,180
Closed -$458K 1366
2025
Q1
$458K Buy
7,180
+153
+2% +$9.76K 0.01% 909
2024
Q4
$854K Sell
7,027
-134
-2% -$16.3K 0.02% 625
2024
Q3
$894K Buy
7,161
+994
+16% +$124K 0.02% 648
2024
Q2
$975K Buy
+6,167
New +$975K 0.02% 592
2018
Q4
Sell
-1,520
Closed -$245K 1539
2018
Q3
$245K Buy
+1,520
New +$245K 0.01% 1442